Drug intelligence / Profile preview

cucurbitacin D

Development stage
Preclinical
Modality
Classical Binding Small Molecules → Small Molecules
Administration
Intratumoral, Intraperitoneal, Oral, Rectal, Transdermal
01

Overview

**Cucurbitacin D** is a highly oxygenated tetracyclic triterpenoid natural product found in plants such as Cucurbita texana and Ecballium elaterium. It exerts potent **anti-cancer and pro-apoptotic activity** in a range of cancer cell models, including cervical, breast, and colorectal cancers[1][4][7][16]. Its mechanism of action includes the disruption of Hsp90 (heat shock protein 90) and co-chaperone (Cdc37 and p23) interactions, leading to impaired maturation of Hsp90-dependent client proteins (such as Her2, Raf, Cdk6, and pAkt)[2][15]; inhibition of the PI3K-Akt, JAK-STAT, and ErbB signaling pathways; reduction of phosphorylated STAT3, Akt, and NF-κB signaling; induction of apoptosis via effects on PARP cleavage, p53, Bcl-2, and caspase-3; and cell cycle arrest at the G1/S phase through downregulation of Cyclin D1 and CDK4 and upregulation of p21 and p27[1][4][7][6].

Other names
(+)-Cucurbitacin DElatericin ACucurbit Delatericineacucurbitacine(d)Cucurbitacin D-RM20,25-tetrahydroxy-phCucurbitacin D(AS)(10α,23E)-2β,16α,20,25-Tetrahydroxy-9β-methyl-19-norlanosta-5,23-diene-3,11,22-trione
02

Targets

PI3K (Phosphoinositide-3-kinase regulatory subunit 6)HSP90 (Heat shock protein 90 chaperone complex)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)NF-κBCCND1 (Cyclin D1)CASP3 (Caspase-3)STAT3 (Signal Transducer and Activator of Transcription 3)

Beyond the preview

Go deeper on cucurbitacin D.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cucurbitacin D.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call